| human | Q5 |
| P2381 | Academic Tree ID | 370586 |
| P496 | ORCID iD | 0000-0002-6429-4760 |
| P1153 | Scopus author ID | 6508223313 |
| P1556 | zbMATH author ID | laeyendecker.oliver |
| P69 | educated at | Johns Hopkins University | Q193727 |
| Johns Hopkins Bloomberg School of Public Health | Q858206 | ||
| P108 | employer | National Institute of Allergy and Infectious Diseases | Q3519875 |
| P735 | given name | Oliver | Q2110096 |
| Oliver | Q2110096 | ||
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q57875293 | 2: Twenty Years Experience With HIV Testing among Emergency Department Patients at the Johns Hopkins Hospital |
| Q57875303 | 41: Seroprevalence of HSV-2 Infection Among an Urban Emergency Department Patient Population |
| Q33812743 | A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation |
| Q36683821 | A serial risk score approach to disease classification that accounts for accuracy and cost |
| Q37423475 | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
| Q94048822 | A22 Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore |
| Q37511426 | Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons |
| Q37448840 | Aetiology of genital ulcer disease in female partners of male participants in a circumcision trial in Uganda |
| Q28554904 | Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061) |
| Q35965218 | Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis |
| Q34608508 | Antibody maturation and viral diversification in HIV-infected women |
| Q27312940 | Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061 |
| Q40458433 | Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). |
| Q36419479 | Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda |
| Q37176914 | Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda |
| Q35688075 | Association of recent HIV infection and in-utero HIV-1 transmission |
| Q47559811 | Associations between friendship characteristics and HIV and HSV-2 status amongst young South African women in HPTN-068. |
| Q40226580 | Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays |
| Q35854698 | Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study |
| Q34012387 | C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation |
| Q33589257 | Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265) |
| Q34249219 | Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. |
| Q34620235 | Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users |
| Q33999996 | Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial |
| Q33822714 | Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda |
| Q36889651 | Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study |
| Q50089242 | Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial |
| Q35230246 | Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. |
| Q36288430 | Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma |
| Q37050729 | Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda |
| Q36844905 | Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China |
| Q47564118 | Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population |
| Q42333504 | Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe |
| Q91026973 | Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore |
| Q53274310 | Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'. |
| Q57874529 | Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the ‘Mean Duration of Recent Infection’ |
| Q37080530 | Cross-sectional HIV incidence estimation in HIV prevention research |
| Q34283270 | Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda |
| Q36169234 | Detection of Acute and Early HIV-1 Infections in an HIV Hyper-Endemic Area with Limited Resources |
| Q37347026 | Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay |
| Q33893570 | Determinants of the quantity of hepatitis C virus RNA. |
| Q89772883 | Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART) |
| Q40751062 | Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations |
| Q35043592 | Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial |
| Q35678689 | Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda |
| Q36930427 | Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections |
| Q37025719 | Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda |
| Q34038548 | Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial |
| Q34129740 | Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda |
| Q38876725 | Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection |
| Q34598155 | Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection |
| Q36314074 | Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics |
| Q30912200 | Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials |
| Q35799147 | Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression |
| Q42348733 | Erratum to: Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment |
| Q34848161 | Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). |
| Q36764936 | Estimation of HIV incidence using multiple biomarkers |
| Q56909994 | Ethical considerations in global HIV phylogenetic research |
| Q36578746 | Evaluation of hidden HIV infections in an urban ED with a rapid HIV screening program |
| Q37216301 | Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda |
| Q92548129 | Evaluation of phylogenetic methods for inferring the direction of HIV transmission: HPTN 052 |
| Q57875463 | Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR |
| Q33809708 | Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller |
| Q36102525 | Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay |
| Q101473395 | Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore |
| Q37461069 | Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda |
| Q34205686 | Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening |
| Q38697223 | False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection |
| Q33723141 | Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda |
| Q33750736 | Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data |
| Q35914336 | Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2. |
| Q37448848 | Geographic HIV type 1 subtype distribution in Rakai district, Uganda |
| Q35914319 | Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins |
| Q34284388 | Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors |
| Q35772424 | HIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency Department |
| Q46469073 | HIV Prevention Efforts and Incidence of HIV in Uganda |
| Q35588137 | HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels |
| Q37546766 | HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm |
| Q36495553 | HIV incidence determination in the United States: a multiassay approach |
| Q35547098 | HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study |
| Q34135328 | HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda |
| Q33624877 | HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda |
| Q34028918 | HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). |
| Q36050122 | HIV type 1 genetic variation in foreskin and blood from subjects in Rakai, Uganda |
| Q37395319 | HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression |
| Q30389893 | HIV-1 Sequence Data Coverage in Central East Africa from 1959 to 2013. |
| Q37444204 | HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners |
| Q34023818 | HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda |
| Q33576652 | HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda |
| Q33882090 | HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda |
| Q35927705 | HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa-Study Design and Baseline Results |
| Q99613379 | Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 |
| Q35683053 | Hepatitis B virus and sexual behavior in Rakai, Uganda |
| Q37709687 | Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China |
| Q35137055 | High HIV burden among people who inject drugs in 15 Indian cities |
| Q35633507 | High HIV prevalence and incidence among MSM across 12 cities in India |
| Q37342633 | High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda |
| Q34591699 | High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore |
| Q35125231 | High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda |
| Q37363152 | How effectively can HIV phylogenies be used to measure heritability? |
| Q27469782 | Human Immunodeficiency Virus Seroconversion and Evolution of the Hepatitis C Virus Quasispecies |
| Q27469647 | Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees |
| Q52681670 | Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. |
| Q57165306 | Identification of HIV Superinfection in Seroconcordant Couples in Rakai, Uganda, by Use of Next-Generation Deep Sequencing |
| Q35139723 | Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing |
| Q37245203 | Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. |
| Q35904511 | Identification of new CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates |
| Q38852280 | Identifying Transmission Clusters with Cluster Picker and HIV-TRACE. |
| Q100753276 | IgM autoantibodies recognizing ACE2 are associated with severe COVID-19 |
| Q37617869 | Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay |
| Q37686158 | Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda |
| Q33654658 | Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda |
| Q36672554 | Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda |
| Q36438781 | Improvements in the continuum of HIV care in an inner-city emergency department |
| Q91892044 | Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks |
| Q33916829 | Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay |
| Q33813282 | Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore |
| Q33883704 | Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans |
| Q36210055 | Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction |
| Q28534491 | Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection |
| Q57875339 | Laboratory Testing for HIV Infection |
| Q57874934 | Laboratory testing for HIV infection |
| Q42636699 | Long-term control of viral replication in a Group O, human immunodeficiency virus type 1-infected individual |
| Q36414171 | Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation |
| Q33902563 | Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda |
| Q29619176 | Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial |
| Q37178782 | Male circumcision for the prevention of HSV-2 and HPV infections and syphilis |
| Q37154019 | Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa |
| Q35267729 | Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms |
| Q39708947 | Molecular epidemiology of HIV-1 subtypes in southern China. |
| Q36994022 | Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department |
| Q37419798 | Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans |
| Q35080053 | Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States |
| Q35683057 | Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA. |
| Q35061134 | Phylodynamic profile of HIV-1 subtype B, CRF01_AE and the recently emerging CRF51_01B among men who have sex with men (MSM) in Singapore |
| Q62487956 | Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort |
| Q35794339 | Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment |
| Q47831175 | Predominance of defective proviral sequences in an HIV + long-term non-progressor |
| Q33719217 | Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay |
| Q33921519 | Prevalence and factors associated with herpes simplex virus type 2 infection in patients attending a Baltimore City emergency department |
| Q36305433 | Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions |
| Q38881073 | Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda |
| Q35621541 | Relationship between community-level alcohol outlet accessibility and individual-level herpes simplex virus type 2 infection among young women in South Africa |
| Q45948519 | Response to using incidence assays within the context of the recent infections testing algorithm. |
| Q57874671 | Safety of Optimized Antiretroviral Therapy During Allogeneic Matched and Haploidentical Bone Marrow Transplant in HIV+ Individuals |
| Q31133298 | Segmented polynomials for incidence rate estimation from prevalence data |
| Q37370674 | Selection of HIV variants with signature genotypic characteristics during heterosexual transmission |
| Q40285384 | Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence |
| Q36330026 | Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China |
| Q40440245 | Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection |
| Q30379416 | Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. |
| Q36250409 | Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries |
| Q38876861 | Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda |
| Q30374503 | The Relationship between Alcohol Outlets, HIV Risk Behavior, and HSV-2 Infection among South African Young Women: A Cross-Sectional Study. |
| Q40463407 | The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. |
| Q34064330 | The effect of sample handling on cross sectional HIV incidence testing results |
| Q37335555 | The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department |
| Q33974693 | The natural history of hepatitis C virus infection: host, viral, and environmental factors |
| Q28268308 | The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda |
| Q28658229 | The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models |
| Q37136842 | Transactional sex among young women in rural South Africa: prevalence, mediators and association with HIV infection |
| Q34055207 | Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach |
| Q38878184 | Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda |
| Q40832940 | Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection |
| Q28743210 | Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection |
| Q36495534 | Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study |
| Q36452397 | Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam |
| Q33788085 | Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe |
| Q40145384 | Weak HIV Antibody Responses in Perinatally-Infected Young Adults |
Search more.